drugset / Trial / NCT02101866
A Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Formulations in Healthy Volunteers
RandomizedCrossoverOpen-labelOther
Summary
This Phase 1 study aims to determine the oral bioavailability of a single dose of a new vapendavir tablet formulation and compare it to that of the previous vapendavir capsule formulation. The safety of both drug products will also be assessed.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-05
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vapendavir | Small molecule | 132 mg | Oral |
| Subject | Vapendavir | Small molecule | 300 mg | Oral |
Indications
No indication recorded.